BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36255606)

  • 21. Resection of hilar cholangiocarcinoma with left hepatectomy after pre-operative embolization of the proper hepatic artery.
    Yasuda Y; Larsen PN; Ishibashi T; Yamashita K; Toei H
    HPB (Oxford); 2010 Mar; 12(2):147-52. PubMed ID: 20495660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic cholangiocarcinoma: Limitations for resectability, current surgical concepts and future perspectives.
    Machairas N; Lang H; Jayant K; Raptis DA; Sotiropoulos GC
    Eur J Surg Oncol; 2020 May; 46(5):740-746. PubMed ID: 32007379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
    Scott A; Wong P; Melstrom LG
    Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
    Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrahepatic Carcinosarcoma With Cholangiocarcinoma Elements and Prominent Bile Duct Spread.
    Usui G; Hashimoto H; Kusakabe M; Shirota G; Sugiura Y; Fujita Y; Satou S; Harihara Y; Horiuchi H; Morikawa T
    Int J Surg Pathol; 2019 Dec; 27(8):900-906. PubMed ID: 31203684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgery of extrahepatic bile duct cancer - current evidence and recommendations.
    Nikov A; Gürlich R
    Rozhl Chir; 2022; 101(9):416-420. PubMed ID: 36257799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review.
    Sposito C; Droz Dit Busset M; Virdis M; Citterio D; Flores M; Bongini M; Niger M; Mazzaferro V
    Eur J Surg Oncol; 2022 Jan; 48(1):150-159. PubMed ID: 34412956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Liver-Directed Local Therapy With Overall Survival in Adults With Metastatic Intrahepatic Cholangiocarcinoma.
    Sebastian NT; Tan Y; Miller ED; Williams TM; Noonan AM; Hays JL; Abdel-Misih S; Diaz DA
    JAMA Netw Open; 2019 Sep; 2(9):e1911154. PubMed ID: 31517963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
    Yang XG; Sun YY; Li DS; Xu GH; Huang XQ
    Front Immunol; 2022; 13():940009. PubMed ID: 35874708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholangiocarcinoma-Intrahepatic to hilar bile duct cancer].
    Rademacher S; Denecke T; Berg T; Seehofer D
    Chirurgie (Heidelb); 2022 Jul; 93(7):644-651. PubMed ID: 35771272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma.
    Nagino M; Nimura Y; Kamiya J; Kondo S; Uesaka K; Kin Y; Kutsuna Y; Hayakawa N; Yamamoto H
    Surgery; 1995 Jun; 117(6):677-81. PubMed ID: 7778031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
    Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
    Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of surgical treatment for hepatolithiasis-associated intrahepatic cholangiocarcinoma: A retrospective study in a single institution.
    Xiao J; Zhu J; Liu Z; Wan R; Li Y; Xiao W
    J Cancer Res Ther; 2017; 13(5):756-760. PubMed ID: 29237899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
    Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival.
    Marquardt S; Kirstein MM; Brüning R; Zeile M; Ferrucci PF; Prevoo W; Radeleff B; Trillaud H; Tselikas L; Vicente E; Wiggermann P; Manns MP; Vogel A; Wacker FK
    Eur Radiol; 2019 Apr; 29(4):1882-1892. PubMed ID: 30255257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: a Critical and Updated Review of the Literature.
    Lluís N; Asbun D; Wang JJ; Cao HST; Jimenez RE; Alseidi A; Asbun H
    J Gastrointest Surg; 2023 Dec; 27(12):3001-3013. PubMed ID: 37550590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma.
    Kida A; Mizukoshi E; Kitahara M; Miyashita T; Goto S; Kamigaki T; Takimoto R; Asai J; Kakinoki K; Urabe T; Tomita K; Kaneko S
    Int J Cancer; 2024 Feb; 154(4):738-747. PubMed ID: 37676069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
    Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
    Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical resection criteria and neoadjuvant therapies for intrahepatic cholangiocarcinoma.
    O'Bryan J; Sadagopan N; Winslow E; Radkani P; Fishbein T; Banovac F; Cohen E; Hartley ML; He AR
    Clin Adv Hematol Oncol; 2023 Nov; 21(11):584-591. PubMed ID: 37948594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.